SBC Medical Group Holdings Inc
SBCNasdaq
$3.08
↓ -2.8%Jul 17 close · end-of-day
Price
1Y↓ -41.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$315.9M
Enterprise Value
$188.8M
P/E
7.7
P/S
1.9
P/B
1.2
EV/EBITDA
3.0
PEG
—
FCF Yield
9.7%
Dividend Yield
—
Revenue (TTM)
$169.3M
Net Income (TTM)
$40.8M
Free Cash Flow (TTM)
$30.7M
Gross Margin
70.8%
Operating Margin
36.0%
Net Margin
24.1%
ROE
16.0%
ROIC
28.0%
Debt / Equity
0.2
Net Cash
$127.2M
Return 1Y
-43.9%
Company profile
SBC Medical Group Holdings, a Delaware corporation incorporated on January 20, 2023, is headquartered in Tokyo, Japan. SBC owns and provides management services to cosmetic treatment centers mainly in Japan.
- CEO
- Yoshiyuki Aikawa
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- California
- Website
- sbc-holdings.com
Earnings
SBC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$43.1M↓ -9.0%
Diluted EPS$0.11↓ -47.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $193.5M | $205.4M | $173.6M |
| Gross profit | $137.3M | $156.1M | $127.3M |
| Operating income | $70.7M | $70.3M | $67.5M |
| Net income | $39.4M | $46.6M | $51.0M |
| Diluted EPS | $0.42 | $0.48 | $0.50 |
| Operating cash flow | $50.7M | $20.6M | $24.7M |
| Free cash flow | $42.1M | $18.0M | $23.3M |
| Gross margin | 70.9% | 76.0% | 73.3% |
| Operating margin | 36.5% | 34.2% | 38.9% |
| Net margin | 20.3% | 22.7% | 29.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $53.1M | $53.1M | $44.4M | $47.3M | $43.4M | $43.4M | $39.6M | $43.1M |
| Gross profit | $39.4M | $43.2M | $33.9M | $37.7M | $30.0M | $30.6M | $28.9M | $30.3M |
| Operating income | $27.3M | $13.8M | $4.7M | $24.2M | $14.6M | $15.9M | $12.8M | $17.7M |
| Net income | $18.5M | $2.8M | $6.5M | $21.5M | $2.5M | $12.8M | $14.2M | $11.3M |
| Diluted EPS | $0.20 | $0.03 | $0.05 | $0.21 | $0.02 | $0.12 | $0.15 | $0.11 |
| Operating cash flow | $19.2M | $5.0M | -$7.3M | $1.9M | -$8.3M | -$20.9M | $52.0M | $9.2M |
| Free cash flow | $18.3M | $4.6M | -$7.9M | $1.7M | -$8.6M | -$20.9M | $51.2M | $9.1M |
| Gross margin | 74.2% | 81.5% | 76.3% | 79.7% | 69.2% | 70.6% | 73.1% | 70.5% |
| Operating margin | 51.4% | 26.1% | 10.6% | 51.1% | 33.6% | 36.6% | 32.5% | 41.2% |
| Net margin | 34.8% | 5.3% | 14.7% | 45.4% | 5.7% | 29.6% | 35.9% | 26.3% |
Company news
Jul 11, 2026
Jun 30, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-28 | Aikawa Yoshiyuki· Chairman and CEO | Sale | 465,000 | $3.02 | $1.4M | filing |
| 2026-04-21 | Aikawa Yoshiyuki· Chairman and CEO | Sale | 3,100,000 | $3.02 | $9.4M | filing |
| 2026-03-06 | Aikawa Yoshiyuki· Chairman and CEO | Sale | 4,422,900 | $2.12 | $9.4M | filing |
Latest 3 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.